VBIV: Two Investor Conferences in June 2021
Jun 1, 2021 12:34:08 GMT
investobefree22 and gatokity like this
Post by icemandios on Jun 1, 2021 12:34:08 GMT
VBI Vaccines to Participate in Upcoming Investor Conferences
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, President and Chief Executive Officer, and David E. Anderson, Ph.D., Chief Scientific Officer, will participate in analyst-led fireside chats at the following upcoming investor conferences:
Jefferies Virtual Healthcare Conference
Analyst discussion to be held with Kelechi Chikere, Ph.D.
Date: Thursday, June 3, 2021
Time: 1-1:25 PM ET
Webcast Link: wsw.com/webcast/jeff174/vbiv/1864593
Raymond James Human Health Innovation Conference
Analyst discussion to be held with Steven Seedhouse, Ph.D.
Date: Wednesday, June 23, 2021
Time: 12-12:30 PM ET
Webcast Link: kvgo.com/rj-health/vbi-vaccines-inc-june-2021
Live webcasts of the presentations will also be available on the Investors page of VBI’s website at: www.vbivaccines.com/investors/events-and-presentations/ . A replay of each webcast will be archived on the Company’s website following the presentation.
About VBI Vaccines Inc.
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel.
VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that Jeff Baxter, President and Chief Executive Officer, and David E. Anderson, Ph.D., Chief Scientific Officer, will participate in analyst-led fireside chats at the following upcoming investor conferences:
Jefferies Virtual Healthcare Conference
Analyst discussion to be held with Kelechi Chikere, Ph.D.
Date: Thursday, June 3, 2021
Time: 1-1:25 PM ET
Webcast Link: wsw.com/webcast/jeff174/vbiv/1864593
Raymond James Human Health Innovation Conference
Analyst discussion to be held with Steven Seedhouse, Ph.D.
Date: Wednesday, June 23, 2021
Time: 12-12:30 PM ET
Webcast Link: kvgo.com/rj-health/vbi-vaccines-inc-june-2021
Live webcasts of the presentations will also be available on the Investors page of VBI’s website at: www.vbivaccines.com/investors/events-and-presentations/ . A replay of each webcast will be archived on the Company’s website following the presentation.
About VBI Vaccines Inc.
VBI Vaccines Inc. (“VBI”) is a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease. Through its innovative approach to virus-like particles (“VLPs”), including a proprietary enveloped VLP (“eVLP”) platform technology, VBI develops vaccine candidates that mimic the natural presentation of viruses, designed to elicit the innate power of the human immune system. VBI is committed to targeting and overcoming significant infectious diseases, including hepatitis B, coronaviruses, and cytomegalovirus (CMV), as well as aggressive cancers including glioblastoma (GBM). VBI is headquartered in Cambridge, Massachusetts, with research operations in Ottawa, Canada, and a research and manufacturing site in Rehovot, Israel.